Advertisement

Papilledema

  • An-Guor Wang
Chapter

Abstract

A 56-year-old male presented with complaints of blurry vision and floaters in the right eye for a few days. He denied any past medical history of systemic disease but cited suffering from chronic headaches. Recently, a visual floater and blurred vision was noticed in the right eye. Visual acuity was 6/4 in the right eye and 6/5 in the left. He could identify only two plates OD and three plates OS with the Ishihara color test. Both anterior segments were normal. Fundoscopic examination revealed a moderate degree of disc edema with splinter hemorrhages in both eyes (Fig. 15.1). Fluorescein angiography showed capillary dilation over the optic disc in early phase, with dye staining at late phase (Fig. 15.2). Right homonymous hemianopia was found on visual field examination (Fig. 15.3). MRI showed a heterogeneously enhanced tumor measuring 6.6 × 4.0 × 5.1 cm in the left occipital region, with calcifications and necrotic components. In addition, an enlarged CSF space along the optic nerves was observed bilaterally on T2-weighted images (Fig. 15.4). The patient was confirmed to have lung cancer with brain metastasis and subsequently began whole brain radiotherapy and Iressa treatment.

References

  1. 1.
    Rigi M, Almarzouqi SJ, Morgan ML, Lee AG. Papilledema: epidemiology, etiology, and clinical management. Eye Brain. 2015;7:47–57.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Hainline C, Rucker JC, Balcer LJ. Current concepts in pseudotumor cerebri. Curr Opin Neurol. 2016;29(1):84–93.CrossRefPubMedGoogle Scholar
  3. 3.
    Wall M, George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol. 1987;44:170–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Rook BS, Phillips PH. Pediatric pseudotumor cerebri. Curr Opin Ophthalmol. 2016;27(5):416–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Invest Ophthalmol Vis Sci. 2011;52(9):6558–64.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(4):400–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Julayanont P, Karukote A, Ruthirago D, Panikkath D, Panikkath R. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res. 2016;9:87–99.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Sobel RK, Syed NA, Carter KD, Allen RC. Optic nerve sheath fenestration: current preferences in surgical approach and biopsy. Ophthal Plast Reconstr Surg. 2015;31(4):310–2.CrossRefPubMedGoogle Scholar
  9. 9.
    Xu K, Yu T, Yuan Y, Yu J. Current status of the application of intracranial venous sinus stenting. Int J Med Sci. 2015;12(10):780–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mulroy E, Krishnan T, Best S, Anderson NE. Forgetting the fundoscope - A case of fulminant idiopathic intracranial hypertension causing rapid visual loss. J Clin Neurosci. 2018;50:108–10.CrossRefPubMedGoogle Scholar
  11. 11.
    Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep. 2007;11:62–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Bruce BB, Preechawat P, Newman NJ, Lynn MJ, Biousse V. Racial differences in idiopathic intracranial hypertension. Neurology. 2008;70:861–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • An-Guor Wang
    • 1
  1. 1.Department of OphthalmologyTaipei Veterans General Hospital, National Yang-Ming University School of Medicine, Yun-San Ophthalmology Education Research FoundationTaipeiTaiwan

Personalised recommendations